There is significant potential in decentralized models and digital health technology to expand diversity in clinical trials.
Monica Chmielewski and Alexandra Maulden
Advertisement
Articles by Monica Chmielewski and Alexandra Maulden
Advertisement
Latest Updated Articles
An Overview of FDA Diversity-Related Documents for Clinical TrialsPublished: May 30th 2024 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Outlines New Superiority Standard for Future CAR-T Approvals
2
Accelerating Clinical Trial Timelines with AI
3
Noteworthy Focus Points That Help Differentiate Anti-Obesity Drug Development Strategies in a Rapidly Evolving and Expanding R&D Landscape
4
When AI Learns to Speak Every Language: An eCOA Migration Study
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
